PATENT CLAIM ANALYSIS

Application Number: 16124269
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "054000"]

Abstract:
The present invention relates to the use of chondroitin as a transdermal carrier and slow-release system for active ingredients in pharmaceutical and cosmeceutical compositions.

Claim (Index 3):
The method according to  claim 1 , wherein said complexes are administered topically, nasally, rectally or vaginally.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.04167
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14400069', '14977119', '10896546', '13112696', '13322185']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.72869817631302
- 35 USC 102 Novelty (BERT): 0.5109982858264385
- Combined Prediction Score: 0.7069281872643619
- Mean Citation Score: 134.57041099999998
- Max Citation Score: 175.5527
- Similarity Product: 99.04360770713686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test